• No results found

Catalytic synthesis of benzimidazole derivatives over modified forms of zirconia

N/A
N/A
Protected

Academic year: 2022

Share "Catalytic synthesis of benzimidazole derivatives over modified forms of zirconia "

Copied!
8
0
0

Loading.... (view fulltext now)

Full text

(1)

Electronic Supplementary Data

Catalytic synthesis of benzimidazole derivatives over modified forms of zirconia

T E Mohan Kumara, b, S Z Mohamed Shamshuddina, b, *, Venkatesha, b & S Reena Sarithaa, b

aChemistry Research Laboratory, HMS Institute of Technology, NH4, Kyathsandra, Tumakuru 572 104, Karnataka, India

bResearch and Development Center, Bharathiar University, Coimbatore 572 104, India Email: mohamed.shamshuddin@gmail.com

No. Contents Pg No.

1 Table S1 – Synthesis of various benzimidazole derivatives over Mo(VI)/ZrO2 solid acid catalyst.

[React. cond.: Reaction temp. = 80 °C; solvent = 20 mL ethanol; molar ratio of aldehyde: diamine

= 1:1; weight of the MZ catalyst = 0.06 g]

2

2 Table S2 – Effect of reusability on the yield of benzimidazoles over ZrO2, Mo(VI)/ZrO2 and Pt-SO42-/ZrO2. [React. cond.: React. temp. = 80 °C; react. time = 3 h; solvent = 20 mL ethanol;

molar ratio of 3,5-dimethyl-benzaldehyde: 4,5-dimethyl-benzene-1,2-daimine = 1:1; weight of solid acid catalyst = 0.06 g]

5

3 Fig. S1 – PXRD pattern of pure zirconia calcined at 300 oC 5

4 Appendix S1 5

(2)

Table S1 – Synthesis of various benzimidazole derivatives over Mo(VI)/ZrO2 solid acid catalyst. [React. cond.: Reaction temp. = 80 °C; solvent = 20 mL ethanol; molar ratio of aldehyde: diamine = 1:1; weight of the MZ catalyst = 0.06 g]

Entry Aldehyde Diamine Product Time

(h)

Yield (%)

1

O H

NH2

NH2

N H N

3.0 53.1

2

O H

NH2

NH2

N N

3.0 22.2

3

O H

NH2

NH2 O

N H N

O

N N H

O and

1.0 82.1

4

O H

NH2

NH2 N

H

N 1.0 59.3

(3)

5

O H

NH2

NH2 N

N 1.0 31.6

6

O H

NH2

NH2 N

H N

N NH and

1.0 72.4

7

O H

O

NH2

NH2 N

H N

O

1.0 84.2

8 O H

Cl

Cl

NH2

NH2

NH N

Cl

Cl

N

NH Cl

and

1.0 98.1

(4)

9 O H Cl

Cl

NH2

NH2 O

NH N

Cl

Cl

O

N NH

Cl

Cl

O and

2.0 70.2

10

O H

F F F

F

NH2 NH2

F N

H N

F

F F F F

N NH

F

F F F F

and

2.0 82.6

11

O H

F F F

F

NH2

NH2 N

H N

F

F F F

1.0 93.7

12

O H

F F F

F

NH2

NH2

O N

H N

F F

F O F

NH

F and

2.0 91.1

(5)

Table S2 – Effect of reusability on the yield of benzimidazoles over ZrO2, Mo(VI)/ZrO2 and Pt-SO42-

/ZrO2. [React. cond.: React. temp. = 80 °C; react. time = 3 h; solvent = 20 mL ethanol; molar ratio of 3,5-dimethyl- benzaldehyde: 4,5-dimethyl-benzene-1,2-daimine = 1:1; weight of solid acid catalyst = 0.06 g]

Reaction cycle (no.)

Z MZ Pt-SZ

Yield (%) of Product-A

Yield (%) of Product-B

Yield (%) of Product-A

Yield (%) of Product-B

Yield (%) of Product-A

Yield (%) of Product-B

1 (Fresh) 24.1 11.3 53.1 22.2 61.6 26.2

2 23.9 11.2 52.6 22.0 60.1 25.6

3 23.6 11.0 52.1 21.7 58.2 25.1

4 23.2 10.8 51.7 21.5 56.4 24.2

5 23.0 10.5 51.2 21.2 53.1 23.1

Product-A = 2-(3,5-dimethylphenyl)-5,6-dimethyl-1H-benzo[d]imidazole.

Product-B = 1-(3,5-dimethylbenzyl)-2-(3,5-dimethylphenyl)-5,6-dimethyl-1H-benzo[d]imidazole.

Fig. S1 – PXRD pattern of pure zirconia calcined at 300 oC

Appendix S1 – 1H NMR, 13C NMR, LC-MS, HPLC data, physical state and melting point of the synthesized benzimidazole derivatives (Refer to Table 2).

Entry 1:

2-(3,5-dimethylphenyl)-5,6-dimethyl-1H-benzo[d]imidazole

1H NMR (DMSO-d6, 400 MHz): δ (ppm) 2.286 (s, 3H), 2.302 (s, 3H), 2.334 (s, 6H), 7.060 (s, 1H), 7.240 (s, 1H), 7.372 (s, 1H), 7.740 (s, 2H), 12.485 (s, 1H, D2O exchangeable). 13C NMR (DMSO-d6, 100 MHz):

δ (ppm) 20.434, 21.386, 111.697, 119.258, 124.449, 130.182, 130.786, 131.274, 131.391, 133.932, 138.309, 142.965, 150.999. Calculated for C17H18N2 [M+H]+: 251.15, found [M+H]+: 251.1; physical state: off-white solid; melting point: 303-305 °C.

Entry 2:

(6)

Calculated for C26H28N2 [M+H]+: 369.23, found [M+H]+: 369.2; physical state: off-white solid; melting point: 185-187 °C.

Entry 3:

2-(3,5-dimethylphenyl)-5-methoxy-1H-benzo[d]imidazole and 2-(3,5-dimethylphenyl)-6-methoxy-1H- benzo[d]imidazole

1H NMR (DMSO-d6, 400 MHz): δ (ppm) 2.339 (s, 6H), 3.775 (d, 3H, J = 7.6 Hz), 6.795 (t, 1H, J = 9.6 Hz), 6.937 (s, 0.5H), 7.073 (d, 1H, J = 4.4 Hz), 7.137 (s, 0.5H), 7.350 (d, 0.5H, J = 8.4 Hz), 7.483 (d, 0.5H, J = 8.8 Hz), 7.727 (d, 2H, J = 7.6 Hz), 12.602 (d, 1H, J = 7.2 Hz, D2O exchangeable). 13C NMR (DMSO-d6, 100 MHz): δ (ppm) 21.394, 55.916, 94.854, 101.866, 111.588, 119.638, 124.387, 130.678, 131.329, 136.085, 138.355, 145.127, 151.278, 156.275. Calculated for C16H16N2O [M+H]+: 253.13, found [M+H]+: 253.1; physical state: light brown solid; melting point: 176-178 °C.

Entry 4:

2-(4-isopropylphenyl)-5,6-dimethyl-1H-benzo[d]imidazole

1H NMR (DMSO-d6, 400 MHz): δ (ppm) 1.223 (d, 6H, J = 7.2 Hz), 2.283 (s, 3H), 2.305 (s, 3H), 2.914- 2.948 (m, 1H), 7.235 (s, 1H), 7.366 (d, 3H, J = 7.6 Hz), 8.023 (d, 2H, J = 8.0Hz), 12.474 (s, 1H, D2O exchangeable). 13C NMR (DMSO-d6, 100 MHz): δ (ppm) 20.441, 24.121, 33.759, 111.666, 119.266, 126.711, 127.199, 128.594, 130.166, 131.290, 133.939, 143.011, 150.356, 150.945. Calculated for C18H20N2 [M+H]+: 265.16, found [M+H]+:265.1; physical state: off-white solid; melting point: 223-225

°C.

Entry 5:

1-(4-isopropylbenzyl)-2-(4-isopropylphenyl)-5,6-dimethyl-1H-benzo[d]imidazole

1H NMR (DMSO-d6, 400 MHz): δ (ppm) 1.118 (d, 6H, J = 7.2 Hz), 1.203 (d, 6H, J = 7.2 Hz), 2.255 (s, 3H), 2.289 (s, 3H), 2.778-2.812 (m, 1H), 2.905-2.939 (m, 1H), 5.453 (s, 2H), 6.871 (d, 2H, J = 8.0 Hz), 7.133 (d, 2H, J = 7.6 Hz), 7.168 (s, 1H), 7.343 (d, 2H, J = 8.0 Hz), 7.599 (d, 2H, J = 8.0 Hz). 13C NMR (CDCl3, 100 MHz): δ (ppm) 20.225, 20.510, 23.803, 23.904, 33.712, 34.014, 48.091, 110.589, 119.893, 125.874, 126.726, 127.021, 127.827, 129.159, 131.282, 131.855, 134.156, 134.768, 141.872, 148.202, 150.511, 153.540. Calculated for C28H32N2 [M+H]+: 397.26, found [M+H]+:397.2; physical state: off- white solid; melting point: 174-176 °C.

Entry 6:

5-(tert-butyl)-2-(4-isopropylphenyl)-1H-benzo[d]imidazole and 6-(tert-butyl)-2-(4-isopropylphenyl)-1H- benzo[d]imidazole

1H NMR (DMSO-d6, 400 MHz): δ (ppm) 1.229 (d, 6H, J = 6.8 Hz), 1.332 (s, 9H), 2.922-2.939 (m, 1H), 7.246 (t, 1H, J = 8.8 Hz), 7.386 (d, 3H, J = 8.0 Hz), 7.526 (d, 0.5H, J = 8.4 Hz), 7.595 (s, 0.5H), 8.033 (d, 2H, J = 4.4 Hz), 12.605 (s, 1H, D2O exchangeable). 13C NMR (DMSO-d6, 100 MHz): δ (ppm) 24.121, 32.101, 33.782, 34.844, 34.960, 107.537, 110.899, 115.245, 118.545, 120.002, 120.660, 126.789, 127.269, 128.501, 133.265, 135.380, 142.283, 144.391, 144.685, 145.653, 150.565, 151.619, 151.812.

Calculated for C20H24N2 [M+H]+: 293.19, found [M+H]+: 293.2; physical state: off-white solid; melting point: 203-205 °C.

Entry 7:

2-(4-methoxy-2-methylphenyl)-5,6-dimethyl-1H-benzo[d]imidazole

1H NMR (DMSO-d6, 400 MHz): δ (ppm) 2.284 (s, 3H), 2.301 (s, 3H), 2.568 (s, 3H), 3.789 (s, 3H), 6.875

(7)

160.056. Calculated for C17H18N2O [M+H]+: 267.14, found [M+H]+: 267.1; physical state: off-white solid; melting point: 228-230 °C.

Entry 8:

5-(tert-butyl)-2-(2,5-dichlorophenyl)-1H-benzo[d]imidazole and 6-(tert-butyl)-2-(2,5-dichlorophenyl)- 1H-benzo[d]imidazole

1H NMR (DMSO-d6, 400 MHz): δ (ppm) 1.339 (s, 9H), 7.320 (t, 1H, J = 8.4 Hz), 7.477 (d, 1H, J = 12.8Hz), 7.584 (dd, 2H, J1 = 2.0 Hz, J2 = 8.4 Hz), 7.662 (d, 1H, J = 8.8 Hz), 7.934 (s, 1H), 12.597 (s, 1H, D2O exchangeable). 13C NMR (DMSO-d6, 100 MHz): δ (ppm) 32.062, 35.045, 108.149, 111.619, 115.578, 119.065, 120.552, 121.575, 130.701, 131.127, 131.607, 132.034, 132.382, 132.607, 132.979, 135.117, 141.563, 143.678, 145.157, 146.513, 147.892. Calculated for C17H16Cl2N2 [M+H]+: 319.07, found [M+H]+: 319.0; physical state: off-white solid; melting point: 171-173 °C.

Entry 9:

2-(2,5-dichlorophenyl)-5-methoxy-1H-benzo[d]imidazole and 2-(2,5-dichlorophenyl)-6-methoxy-1H- benzo[d]imidazole

1H NMR (DMSO-d6, 400 MHz): δ (ppm) 3.790 (s, 3H), 6.832-6.855 (m, 1H), 7.026 (s, 0.5H), 7.208 (s, 0.5H), 7.439 (d, 0.5H, J = 8.4 Hz), 7.566 (d, 1.5H, J = 8.8 Hz), 7.653 (d, 1H, J = 9.2 Hz), 7.947 (s, 1H), 12.595 (d, 1H, J = 14.4 Hz, D2O exchangeable). 13C NMR (DMSO-d6, 100 MHz): δ (ppm) 55.932, 94.978, 112.820, 118.135, 120.273, 128.059, 130.531, 130.980, 131.491, 131.855, 132.390, 132.646, 147.443, 156.608. Calculated for C14H10Cl2N2O [M+H]+: 293.02, found [M+H]+: 293.0; physical state:

yellow solid; melting point: 167-169 °C.

Entry 10:

5-fluoro-2-(4-fluoro-2-(trifluoromethyl)phenyl)-1H-benzo[d]imidazole and 6-fluoro-2-(4-fluoro-2- (trifluoromethyl)phenyl)-1H-benzo[d]imidazole

1H NMR (DMSO-d6, 400 MHz): 7.061-7.105 (m, 1H), 7.327 (d, 0.5H, J = 7.6 Hz), 7.460-7.527 (m, 1H), 7.697-7.738 (m, 1.5H), 7.848 (d, 2H, J = 7.2 Hz), 12.882 (s, 1H, D2O exchangeable). 13C NMR (DMSO- d6, 100 MHz): δ (ppm) 98.379, 104.926, 109.985, 110.597, 111.279, 112.735, 114.804, 114.858, 115.059, 115.113, 119.088, 119.839, 120.048, 120.599, 121.815, 124.557, 126.874, 127.269, 129.911, 129.996, 130.228, 130.306, 130.546, 130.624, 130.864, 130.949, 131.894, 135.233, 135.318, 140.532, 144.112, 150.402, 157.886, 160.257, 161.466, 163.945. Calculated for C14H7F5N2 [M+H]+: 299.05, found [M+H]+: 299.3; physical state: off-white solid; melting point: 186-188 °C.

Entry 11:

2-(4-fluoro-2-(trifluoromethyl)phenyl)-5,6-dimethyl-1H-benzo[d]imidazole

1H NMR (DMSO-d6, 400 MHz): δ (ppm) 2.298 (s, 3H), 2.310 (s, 3H), 7.270 (s, 1H), 7.421 (s, 1H), 7.669- 7.710 (m, 1H), 7.797-7.820 (m, 2H), 12.451 (s, 1H, D2O exchangeable). 13C NMR (DMSO-d6, 100 MHz):

δ (ppm) 20.395, 111.852, 114.695, 114.749, 114.951, 115.005, 119.615, 119.715, 119.925, 121.869, 124.596, 127.556, 130.143, 130.228, 130.414, 130.538, 131.855, 133.529, 135.132, 135.218, 142.609, 147.877, 161.241, 163.720. Calculated for C16H12F4N2 [M+H]+: 309.09, found [M+H]+: 309.1; physical

(8)

(ppm) 55.932, 94.823, 101.881, 111.914, 113.200, 114.718, 114.765, 114.974, 115.020, 119.150, 119.762, 119.971, 121.877, 124.604, 127.385, 129.492, 129.779, 129.857, 130.097, 130.174, 130.414, 130.492, 130.732, 135.156, 135.241, 135.613, 138.433, 144.716, 147.776, 155.980, 156.662, 161.264, 163.751. Calculated for C15H10F4N2O [M+H]+: 311.07, found [M+H]+: 311.1; physical state: brown solid;

melting point: 80-82 °C.

References

Related documents

Department of Pharmaceutical Chemistry, COP, MMC, Chennai-03 Page 11 The review of the literature shows that the benzimidazole derivatives square measure effective compound and

Synthesized compounds R1, R2, R3, R6 and R7 were evaluated for anticancer activity by SRB assay method against Human Cancer Cell line A-549. All tested compound exhibit

and enteric neurons, while somatostatin 28 is present in the small intestine. Somatostatin exercise tonic inhibitory effects on parietal cells, however, the

Representative procedure for the preparation of 1,3-diester, 2,4- thiazolidinedione and α -bromopropanoic acid ester derivatives in case of benzimidazole, and 1,3-diester

The effect of poisoning of acid sites of SO 2 4 – or Mo(VI) ions modified zirconia on total surface acidity, powder XRD phases and catalytic activity was also studied..

Further to improve the yield and also to explore the catalytic activity of CAN the reaction was carried out with same amount of reactants in PEG (5 mL) were stirred at 50 ° C in

The results of BET revealed that chromium promoted the dispersion of active copper species and acted as a fence to separate active species from congregating, addition of chromium

et al., 2007 adopted a microwave-assisted method for the synthesis of 2- substituted benzimidazoles (Fig-22) in the presence of Alumina-Methanesulfonic acid (AMA). In